Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled penehyclidine hydrochloride after prolonged general anesthesia in elderly postoperative ICU patients
ChiCTR-TRC-11001458Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of penehyclidine in postoperative respiratory complications (PRC) (3 arms), sponsored by Peking University First Hospital. Primary endpoints: Postoperative pulmonary complications and Pulmonary function. Started Jul 2011; status: completed.
02
Drugs
penehyclidine
03
Conditions
postoperative respiratory complications (PRC)
Beyond the preview
Go deeper on ChiCTR-TRC-11001458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001458.